Hypo-Combi Trial: Hypofractionated EBRT Plus HDR-BT Boost for Prostate Cancer

Conditions:   Prostate Adenocarcinoma;   Radiation Toxicity Interventions:   Radiation: External beam radiation therapy, High-dose-rate brachytherapy;   Drug: Goserelin 10.8 mg Sponsor:   German Oncology Center, Cyprus Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials